Clinical trials for Fibromyalgia

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Fibromyalgia. For all clinical trials, go to clinical trials search

This list shows clinical trials for Fibromyalgia

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Fibromyalgia
Title Recruitment status Location
A Study of ASP2215 (Gilteritinib), Combination of ASP2215 Plus Azacitidine and Azacitidine Alone in the Treatment of Newly Diagnosed Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation in Patients Not Eligible for Intensive Induction Chemotherapy Recruiting United Kingdom
Proof-of-Concept Trial on Selective Removal of sFlt-1 in Pregnant Women With Preeclampsia Via Apheresis Recruiting United Kingdom
A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation Recruiting United Kingdom
A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission Recruiting United Kingdom
A randomised controlled trial to evaluate the effectiveness of a combined education and pool-based exercise programme and usual care in the treatment of patients with fibromyalgia syndrome Not Recruiting United Kingdom
A clinical trial which compares the safety of a not yet approved drug called DS-5565 versus placebo, in patients with pain related to fibromyalgia who also suffer from chronic kidney disease Not Recruiting United Kingdom
A 12-WEEK, OPEN-LABEL, SAFETY TRIAL OF PREGABALIN IN PATIENTS WITH FIBROMYALGIA - N/A Not Recruiting United Kingdom
A randomised, double-blind, placebo-controlled, parallel group study to investigate the safety and efficacy of controlled-release ropinirole (CR) (1-24mg) administered once daily for 12 weeks in subjects with fibromyalgia. Not Recruiting United Kingdom
A Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Xyrem® (sodium oxybate) in Subjects with Fibromyalgia Not Recruiting United Kingdom
Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial Not recruiting United Kingdom

Page last reviewed: 01/03/2016

Next review due: 01/03/2019